October 13, 2009 – Siemens Healthcare reported today at the annual meeting of the European Association of Nuclear Medicine (EANM) in Barcelona, Spain, that leading hospitals in England, France, Germany and Monaco have shown strong interest and adoption of the Biograph mCT, the worlds first molecular CT, to fuel advanced diagnostic capabilities and to drive greater workflow efficiencies.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now